Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Moderate Buy” by Analysts

Phreesia, Inc. (NYSE:PHR) has received a consensus recommendation of “Moderate Buy” from the nineteen research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and twelve have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $20.8235.

A number of brokerages have weighed in on PHR. Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research report on Wednesday, January 28th. Royal Bank Of Canada began coverage on shares of Phreesia in a research report on Friday, January 9th. They set a “moderate buy” rating and a $26.00 target price for the company. Wall Street Zen lowered shares of Phreesia from a “buy” rating to a “hold” rating in a research report on Saturday, April 4th. Truist Financial reiterated a “hold” rating and set a $11.00 target price (down from $24.00) on shares of Phreesia in a research report on Tuesday, March 31st. Finally, Zacks Research lowered shares of Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th.

Insider Activity

In other news, insider David Linetsky sold 8,332 shares of the firm’s stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the transaction, the insider directly owned 224,056 shares in the company, valued at approximately $1,808,131.92. This trade represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Yvonne Hui sold 10,063 shares of the firm’s stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $9.08, for a total transaction of $91,372.04. Following the completion of the transaction, the insider owned 25,991 shares of the company’s stock, valued at $235,998.28. This trade represents a 27.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 50,493 shares of company stock valued at $461,983 over the last ninety days. 5.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Phreesia

A number of large investors have recently modified their holdings of PHR. Granahan Investment Management LLC boosted its position in shares of Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after acquiring an additional 1,018,987 shares during the period. Prosight Management LP bought a new position in shares of Phreesia in the fourth quarter valued at approximately $16,533,000. Millennium Management LLC boosted its position in shares of Phreesia by 730.7% in the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock valued at $25,028,000 after acquiring an additional 936,033 shares during the period. Jacobs Levy Equity Management Inc. bought a new position in shares of Phreesia in the fourth quarter valued at approximately $15,213,000. Finally, OP Asset Management Ltd bought a new position in shares of Phreesia in the first quarter valued at approximately $6,487,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Price Performance

Shares of NYSE:PHR opened at $9.66 on Wednesday. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $587.12 million, a PE ratio of 322.10 and a beta of 0.89. Phreesia has a twelve month low of $7.77 and a twelve month high of $32.76. The company has a 50-day moving average price of $10.37 and a two-hundred day moving average price of $15.24.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). The business had revenue of $127.07 million for the quarter, compared to the consensus estimate of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.Phreesia’s revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.11) EPS. Equities analysts forecast that Phreesia will post 0.28 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.